Literature DB >> 12553504

Primary hemiarthroplasty in old patients with displaced femoral neck fracture: a 1-year follow-up of 103 patients aged 80 years or more.

Cecilia Rogmark1, Ake Carlsson, Olof Johnell, Ingemar Sernbo.   

Abstract

103 patients with displaced femoral neck fractures (Garden 3-4) treated with primary hemiarthroplasty in the Department of Orthopedics, Malmö University Hospital, Sweden 1998-1999 were followed in a prospective, consecutive study for 1 year. Inclusion criteria were age of at least 80 years, signs of mental changes and/or residence in an institution. The control group consisted of 69 patients with internal fixation (Hansson hook pins). The arthroplasty group required more blood transfusions, a longer operation and had more superficial infections. No differences were detected as regards other complications, length of hospital stay, in-hospital mortality or ability to return home. The 1-year mortality rates were similar in the arthroplasty (29/103) and control groups (28/69). Within 1 year, we found a lower failure rate in the arthroplasty group (6/103) than in the control group (18/69). In the arthroplasty group, 2/103 had dislocations. Of the surviving arthroplasty patients at 12 months, 31/74 could walk as well as before the fracture and 55/74 had no pain. We recommend primary hemiarthroplasty for demented and/or institutionalized patients over 80 years with displaced femoral neck fractures.

Entities:  

Mesh:

Year:  2002        PMID: 12553504     DOI: 10.1080/000164702321039534

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  9 in total

1.  Are antibiotics necessary in hip arthroplasty with asymptomatic bacteriuria? Seeding risk with/without treatment.

Authors:  José Cordero-Ampuero; Enrique González-Fernández; David Martínez-Vélez; Jaime Esteban
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

2.  Outcome of treatment of fracture neck of femur using hemiarthroplasty versus dynamic hip screw.

Authors:  Dd Mue; Mn Salihu; F0 Awonusi; Wt Yongu; Jn Kortor; Ic Elachi
Journal:  J West Afr Coll Surg       Date:  2013-04

3.  What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties?

Authors:  José Cordero-Ampuero; Marisol de Dios
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

4.  Global Research Status and Trends of Femoral Neck Fracture Over the Past 27 Years: A Historical Review and Bibliometric Analysis.

Authors:  Peng Peng; Fangjun Xiao; Xiaoming He; Weihua Fang; Jiewen Huang; Bin Wang; Yiwen Luo; Qinwen Zhang; Ying Zhang; Wei He; Qiushi Wei; Mincong He
Journal:  Front Surg       Date:  2022-06-14

5.  Treatment of the displaced femoral neck fracture, as reflected in Acta Orthopaedica Scandinavica.

Authors:  Rolf Onnerfält
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

6.  Early result of hemiarthroplasty in elderly patients with fracture neck of femur.

Authors:  Mue Daniel; Salihu Mohammed; Awonusi Francis; Yongu William; Kortor Joseph; Elachi Cornilius
Journal:  Niger Med J       Date:  2015 Jan-Feb

7.  The influence of cognitive status on outcome and walking ability after hemiarthroplasty for femoral neck fracture: a prospective cohort study.

Authors:  Sebastian Mukka; Björn Knutsson; Ferid Krupic; Arkan S Sayed-Noor
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-10-31

8.  Primary hemiarthroplasty for the elderly patient with cognitive dysfunction and a displaced femoral neck fracture: a prospective, observational cohort study.

Authors:  Ghazi Chammout; Paula Kelly-Pettersson; Carl-Johan Hedbeck; Henrik Bodén; André Stark; Sebastian Mukka; Olof Sköldenberg
Journal:  Aging Clin Exp Res       Date:  2020-07-23       Impact factor: 3.636

9.  Outcomes after fixation for undisplaced femoral neck fracture compared to hemiarthroplasty for displaced femoral neck fracture among the elderly.

Authors:  Jeff Chien-Fu Lin; Wen-Miin Liang
Journal:  BMC Musculoskelet Disord       Date:  2015-08-19       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.